Cargando…
Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States
BACKGROUND: An estimated 166,155 individuals in the United States have undiagnosed HIV infection. We modeled the numbers of HIV-infected individuals who could be diagnosed in clinical and community settings by broadly implementing HIV screening guidelines. SETTING: United States. METHODS: We modeled...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475783/ https://www.ncbi.nlm.nih.gov/pubmed/32885701 http://dx.doi.org/10.1177/2325958220950902 |
_version_ | 1783579583698698240 |
---|---|
author | Kahn, James G. Bendavid, Eran Dietz, Patricia M. Hutchinson, Angela Horvath, Hacsi McCabe, Devon Wolitski, Richard J. |
author_facet | Kahn, James G. Bendavid, Eran Dietz, Patricia M. Hutchinson, Angela Horvath, Hacsi McCabe, Devon Wolitski, Richard J. |
author_sort | Kahn, James G. |
collection | PubMed |
description | BACKGROUND: An estimated 166,155 individuals in the United States have undiagnosed HIV infection. We modeled the numbers of HIV-infected individuals who could be diagnosed in clinical and community settings by broadly implementing HIV screening guidelines. SETTING: United States. METHODS: We modeled testing for general population (once lifetime) and high-risk populations (annual): men who have sex with men, people who inject drugs, and high-risk heterosexuals. We used published data on HIV infections, HIV testing, engagement in clinical care, and risk status disclosure. RESULTS: In clinical settings, about 76 million never-tested low-risk and 2.6 million high-risk individuals would be tested, yielding 36,000 and 55,000 HIV diagnoses, respectively. In community settings, 30 million low-risk and 4.4 million high-risk individuals would be tested, yielding 75,000 HIV diagnoses. CONCLUSION: HIV testing in clinical and community settings diagnoses similar numbers of individuals. Lifetime and risk-based testing are both needed to substantially reduce undiagnosed HIV. |
format | Online Article Text |
id | pubmed-7475783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-74757832020-09-17 Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States Kahn, James G. Bendavid, Eran Dietz, Patricia M. Hutchinson, Angela Horvath, Hacsi McCabe, Devon Wolitski, Richard J. J Int Assoc Provid AIDS Care Original Manuscript BACKGROUND: An estimated 166,155 individuals in the United States have undiagnosed HIV infection. We modeled the numbers of HIV-infected individuals who could be diagnosed in clinical and community settings by broadly implementing HIV screening guidelines. SETTING: United States. METHODS: We modeled testing for general population (once lifetime) and high-risk populations (annual): men who have sex with men, people who inject drugs, and high-risk heterosexuals. We used published data on HIV infections, HIV testing, engagement in clinical care, and risk status disclosure. RESULTS: In clinical settings, about 76 million never-tested low-risk and 2.6 million high-risk individuals would be tested, yielding 36,000 and 55,000 HIV diagnoses, respectively. In community settings, 30 million low-risk and 4.4 million high-risk individuals would be tested, yielding 75,000 HIV diagnoses. CONCLUSION: HIV testing in clinical and community settings diagnoses similar numbers of individuals. Lifetime and risk-based testing are both needed to substantially reduce undiagnosed HIV. SAGE Publications 2020-09-04 /pmc/articles/PMC7475783/ /pubmed/32885701 http://dx.doi.org/10.1177/2325958220950902 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Manuscript Kahn, James G. Bendavid, Eran Dietz, Patricia M. Hutchinson, Angela Horvath, Hacsi McCabe, Devon Wolitski, Richard J. Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States |
title | Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States |
title_full | Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States |
title_fullStr | Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States |
title_full_unstemmed | Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States |
title_short | Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States |
title_sort | potential contributions of clinical and community testing in identifying persons with undiagnosed hiv infection in the united states |
topic | Original Manuscript |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475783/ https://www.ncbi.nlm.nih.gov/pubmed/32885701 http://dx.doi.org/10.1177/2325958220950902 |
work_keys_str_mv | AT kahnjamesg potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates AT bendavideran potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates AT dietzpatriciam potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates AT hutchinsonangela potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates AT horvathhacsi potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates AT mccabedevon potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates AT wolitskirichardj potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates |